Ogawa, T., Oowada, K., Tanba, K., & Hirakawa, K. (2019). ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION. Neurooncol Adv.
Styl ChicagoOgawa, Takahiro, Kei Oowada, Kazuna Tanba, a Kouichi Hirakawa. "ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION." Neurooncol Adv 2019.
Citace podle MLAOgawa, Takahiro, Kei Oowada, Kazuna Tanba, a Kouichi Hirakawa. "ML-14 LOW INVASIVE APPROACH FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATMENT INVOLVING RITUXIMAB–METHOTREXATE + PROCARBAZINE + VINCRISTINE AND TRIPLE INTRATHECAL INJECTION." Neurooncol Adv 2019.